Global Targeting DNA Repair Drugs Supply, Demand and Key Producers, 2023-2029

Global Targeting DNA Repair Drugs Supply, Demand and Key Producers, 2023-2029

The global Targeting DNA Repair Drugs market size is expected to reach $ 1629.7 million by 2029, rising at a market growth of 14.9% CAGR during the forecast period (2023-2029).

In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.

This report studies the global Targeting DNA Repair Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Targeting DNA Repair Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeting DNA Repair Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Targeting DNA Repair Drugs total production and demand, 2018-2029, (K Units)

Global Targeting DNA Repair Drugs total production value, 2018-2029, (USD Million)

Global Targeting DNA Repair Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Targeting DNA Repair Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Targeting DNA Repair Drugs domestic production, consumption, key domestic manufacturers and share

Global Targeting DNA Repair Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Targeting DNA Repair Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Targeting DNA Repair Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Targeting DNA Repair Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Onxeo, FoRx Therapeutics, Artios Pharma Limited, Merck KGaA, Breakpoint Therapeutics, Luciole Pharmaceuticals, AstraZeneca, AbbVie and Johnson & Johnson, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeting DNA Repair Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Targeting DNA Repair Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Targeting DNA Repair Drugs Market, Segmentation by Type
Olaparib
Rucaparib
Niraparib
Talazoparib
Others

Global Targeting DNA Repair Drugs Market, Segmentation by Application
Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer
Breast Cancer
Others

Companies Profiled:
Onxeo
FoRx Therapeutics
Artios Pharma Limited
Merck KGaA
Breakpoint Therapeutics
Luciole Pharmaceuticals
AstraZeneca
AbbVie
Johnson & Johnson
Pfizer
ClovisOncology
GlaxoSmithKline

Key Questions Answered

1. How big is the global Targeting DNA Repair Drugs market?

2. What is the demand of the global Targeting DNA Repair Drugs market?

3. What is the year over year growth of the global Targeting DNA Repair Drugs market?

4. What is the production and production value of the global Targeting DNA Repair Drugs market?

5. Who are the key producers in the global Targeting DNA Repair Drugs market?

6. What are the growth factors driving the market demand?